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1. Introduction 
It is commonly observed that the exposure of cells 
and tissues, possessing a beta receptor linked cyclic 
3',5'-AMP response, with beta adrenergic agonists 
results in a diminished cyclic AMP response to a sub- 
sequent beta adrenergic challenge [I-8]. Among the 
various explanations that have been proposed to 
account for this phenomenon are the following: (i) 
Prolonged beta adrenergic stimulation results in 
elevated intracellular cyclic AMP levels which induce 
an increase in intracellular phosphodiesterase ctivity 
thereby diminishing the net synthesis of cyclic AMP 
[3]. (ii) There is a loss of beta adrenergic binding 
sites in sensitized cells [6] which may result from an 
agonist-induced change in the conformation f the 
receptor. We describe xperiments which suggest that 
beta adrenergic agonist-induced desensitization f 
the cyclic AMP response of the cyclic AMP response 
of rat glioma (C6) cells may not involve levation of 
intracellular cyclic AMP. Further evidence ispresented 
that beta adrenergic desensitization is not dependent 
on enhanced phosphodiesterase. 
2. Materials and methods 
2.1. Rat glioma C6 cell cultures 
We routinely cultured the cells (A.T.C.C. C6[38) 
in Medium 199 supplemented with 10% (v/v) foetal 
bovine serum, 500 units/ml penicillin, 100/ag/ml 
streptomycin, 4.1 mM glutamine and buffered to 
pH 7.5 with 20 mM N-2-hydroxyethylpiperazine. 
N'-2ethanesulfonic acid (Medium A). The cells 
usually grew to confluency in 5-7 days. An atmosphere 
of air was used throughout. Prior to beginning all 
experiments the cultures were equilibrated with 
Eagle's minimal essential medium supplemented as 
previously described [2] (Medium B) at 37°C for 
at least 1 h. 
2.2. Assay of cyclic AMP cell cultures 
This was performed by the method of Brown 
et al. [9] modified as previously described [8]. 
2.3. Assay of  adenylate cyclase activity in broken 
cell preparations 
Cells were grown to confluency in large flat-sided 
glass bottles. The growth medium was poured away 
and the cell sheet rinsed three times with ice-cold 
0.9% NaCI solution. The cells were scraped off the 
glass into a hypotonic solution containing 5mM 
Tris-HC1, pH 7.8 and 75 mM sucrose, left for 
15-30 min at 0°C and then homogenized at2000 
rev/min in a glass-Teflon homogenizer allowing 
1 min for each 5 ml of suspension. Any cells remaining 
intact were broken by a single cycle of freezing and 
thawing after diluting the homogenate with 1 [4 
volume of a buffer containing 20 mM Tris-HC1, pH 7.4, 
"30 mM MgCI2, 5 mM EDTA, 5 mM dithiothreitol and 
0.95 M sucrose. Adenylate cyclase was assayed by 
adding 100 pl of the homogenate (1 mg of protein/ml) 
to 1 ml of a solution containing 50 mM Tris-HCl 
pH 7.4, 10 mM KCI, 5 mM MgC12, 10 mM creatine 
phosphate, 15/ag[ml creatine kinase, 3 mM dithiothreitol, 
and 0.1 mM ATP. The reaction was stopped by trans- 
ferring the tubes to a boiling water bath for 5 min 
and the cyclic AMP content of the heated solutions 
determined. 
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2.4. Assay of phosphodiesterase ctivity in broken 
cell preparations 
The phosphodiesterase ctivity (low K M enzyme) 
of the broken cell preparations of C6 cells was assayed 
by the method of Brooker et al. [10]. 
2.5. Chemicals 
DL-Isoproterenol was purchased from Sigma 
Chemical Company; creatine phosphate and creatine 
kinase from Boehringer, Mannheim. The phospho- 
diesterase inhibitor 2-amino-6-methyl-5-oxo-4-n- 
propyl-4,5-dihydro-s-triazolo (1,5-a) pyrimidine 
(ICI 63,197) is a product of ICI Ltd. [2,8]. 
3. Results 
3.1. Isoproterenol-induced loss of cyclic AMP response 
in C6 cells 
After preincubation with 1/aM isoproterenol for 
2.5 h the response of C6 cells to a subsequent challenge 
with 1 pM isoproterenol was 120 pmoles cyclic AMP/ 
mg protein/10 min compared with a control response 
of 2190 pmoles cyclic AMP/mg protein• 10 min. 
This was the maximal level of desensitization achieved. 
The response to isoproterenol was also depressed after 
incubating the cells with norepinephrine, epinephrine 
or salbutamol (not shown). Although the time course 
of development of desensitization is rather slow 
(t½ = 36 min for all concentrations of agonists, Franklin 
and Twose, unpublished observations), itsinduction 
shows considerable s nsitivity to beta adrenergic 
stimulation (fig.l). The apparent dissociation constant 
(Kd), i.e. the concentration f agonist required for 
half maximal desensitization, fordesensitization f 
C6 cells over 2 hr by isoproterenol was 2.6 nM 
whereas the K d for activation of the cyclic AMP 
response by isoproterenol ver the same time period 
was 30.2 nM. The K d for activation of the cyclic AMP 
response over 10 min was slightly lower but probably 
not significantly different at 18 nM. 
3.2. Adenylate cyclase and phosphodiesterase activity 
in C6 cell homogenate 
Homogenates were prepared from control C6 cells 
and from cells that had been incubated for 2-2.5 h 
with 1/aM isoproterenol. There was a marked stimula- 
tion of cyclic AMP production by isoproterenol in 
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Fig.1. Dose-response curves for the activation of the cyclic 
AMP response and the desensitization f C6 cells by 
isoproterenol. DL-Isoproterenol was used to stimulate the 
cyclic AMP response of confluent cultures of C6 cells over 
10 min (e) and 2 h (o). Parallel cultures were incubated for 
2 h with the indicated concentrations of DL-isoproterenol, 
rinsed three times with fresh medium B and challenged for 
10 min DL-isoproterenol (1 pM) (zx). All challenge incubations 
contained I.C.I. 63,197 (25 lzM). The results (mean of 
duplicate assays on each of two or three cultures) were 
normalized to give % of maximal response, i.e. either of 
stimulation or desensitization. 
homogenates of control cells and the synthesis of 
cyclic AMP continued linearly for at least 1 h. The 
homogenates from cells exposed to isoproterenol 
produced significantly ess cyclic AMP in response to 
isoproterenol (table 1). The responses of these two 
different preparations toNaF were not significantly 
different. The response of mixed homogenate, con- 
taining equal parts from desensitized and control 
cells, to isoproterenol was approximately the mean 
of the responses of the individual homogenates 
(table 1). The K d (1.26/aM) for the activation of the 
adenylate cyclase of homogenates of control cells 
(fig.2) was significantly higher than that for the 
activation of the cyclic AMP response of intact cells 
by isoproterenol. The K d of the desensitized cell 
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Table 1 
Cyclic AMP responses of homogenates of control and desensitized C6 cells 
System Cyclic AMP produced 
(pmoles/mg protein/10 min) 
Control cell homogenate 114 
Control cell liomogenate, 10 pM isoproterenol 494 
Control cell homogenate, 10 mM NaF 415 
J 
Desensitized cell homogenate 96 
Desensitized cell homogenate, 10/aM isoproterenol 233 
Desensitized cell homogenate, 10 mM NaF 466 
Mixed homogenate 93 
Mixed homogenate, 10/aM isoproterenol 341 
Homogenates were prepared from confluent sheets of control C6 cells and cells 
previously incubated for 2 h with 1/aM DL-isoproterenol. The homogenates were 
assayed for adenylate cyclase activity over 10 min. The mixed homogenate contained 
equal parts of the homogenates of control and desensitized cells. All the homo- 
genate incubations contained 25/aM I.C.I. 63,197. Each value is the mean of 
duplicate assays carried out on each of two incubations. 
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Fig.2. Dose-response curves for the cyclic AMP response of 
homogenates of control and desensitized C6 ceils to iso- 
proterenol. Homogenates were prepared from control cells 
(o) and cells incubated for 2.5 h with DL-isoproterenol 
(1/aM) (o). The homogenates were challenged with graded 
concentrations of DL-isoproterenol for 10 min in the 
presence of I.C.I. 63,197 (25/aM). The cyclic AMP produced 
was determined at the end of the incubation. 
homogenate was not significantly different from that 
for the control cell preparation (fig.2). 
Measurements of phosphodiesterase ctivities in 
cell homogenates revealed only a small increase 
(3.6%) in phosphodiesterase ctivity (low K m enzyme) 
in homogenates from desensitized cells (table 2) 
compared with homogenates of control cells. 
4. Discussion 
We have been struck by the apparently greater 
sensitivity of the desensitization phenomenon to beta 
adrenergic agonists when compared with the activation 
of the cyclic AMP response by these agents. In other 
experiments with a variety of agonists using C6 cells 
and also human embryonic fibroblasts we have noted 
that concentrations of agonists that barely elicit a rise 
in the cyclic AMP content of the cultures in 2-3 h 
induce a marked epression i the cyclic AMP response 
to a subsequent isoproterenol challenge. It is possible 
that the induction of desensitization is very highly 
geared to cellular cyclic AMP levels. Alternatively, 
desensitization may not depend on the elevation of 
cyclic AMP but could be triggered by interaction of 
the beta receptor with agonist alone. This could occur 
if the activation of adenylate cyclase by beta adrenergic 
agonists depends on a co-operative interaction between 
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Table 2 
Phosphodiesterase andadenylate cyclase activities in homogenates of control 
and isoproterenol-desensitized C6 cells 
Homogenate 
Phosphodiesterase 
activity 
(pmoles cyclic AMP hydrolyzed 
/10 min/mg protein) 
Adenylate cyclase 
activity 
(pmoles cyclic AMP formed 
/10 min/mg protein) 
Basal Isoproterenol 
stimulated 
Control C6 cells 469 62 577 
Desensitized C6 cells 486 65 120 
Homogenates were prepared from control C6 cells and from cells desensitized by
incubation with 1 tzM DL-isoproterenol f r 2 h. Assays of phosphodiesterase and 
adenylate cyclase activities were carried out Over 10 min in parallel. DL-Isoproterenol 
(1 ~M) was used to stimulate adenylate cyclase activity. Each value is the mean of 
duplicate assays carried out on each of two incubations. 
a minimal number of agonist-receptor complexes. 
Below the necessary threshold level of complexes 
partial desensitization f the receptor pool would be 
possible without activation of adenylate cyclase. 
The results with homogenates of C6 cells strongly 
reinforce our view [2,8] that increased phospho- 
diesterase activity does not provide a general explana- 
tion for the phenomenon of agonist-induced desensitiza- 
tion of the beta-receptor-coupled cyclic AMP response. 
An earlier study from this laboratory [2] found that 
desensitization f cultures of human embryonic fibro- 
blasts is not accompanied by any significant rise in 
phosphodiesterase ctivity. A similar result was 
obtained by DeVellis and Brooker [5] with the 2B 
subclone of C6 cells. The results of experiments in 
which homogenates from control and desensitized 
cells were mixed also indicate that increased phospho- 
diesterase activity is unlikely to account for the 
decline in the cyclic AMP response. The result of 
the mixed homogenate study suggests that, if an 
inhibitor of the beta adrenergic coupled cyclic AMP 
response is formed during desensitization, it must 
either by tightly associated with the receptor-adenylate 
cyclase complex or be in close stoicheometric 
equivalence to it. The beta-receptor-adenylate cyclase 
complexes that remain responsive after desensitiza- 
tion are apparently unchanged in their affinity for the 
agonist. A similar conclusion was reached by 
Mukherjee t al. [6] working with desensitized frog 
erythrocytes. 
The mechanism of the agonist induced loss of the 
cyclic AMP response remains uncertain. It may be 
that in some cells phenomena such as increased 
phosphodiesterase ctivity or the formation of an 
inhibitory protein [5] or some other chemical [7] 
are superimposed on a basic mechanism of desensitiza- 
tion which probably involves a loss of available 
receptor sites as suggested by the work of Lefkowitz's 
group [6,11] possibly induced by agonist-induced 
receptor activation. We suggest, however, that elevated 
intracellular cyclic AMP may not be necessary for 
desensitization to occur. 
During the preparation of this paper, a report 
appeared [12] describing a marked increase (53%) in 
phosphodiesterase ctivity in C6 cells desensitized 
with norepinephrine. This suggests that there may be 
considerable differences between the various lines of 
C6 cells. However, Browning et al. [12] also concluded 
that increased phosphodiesterase does not provide a 
complete xplanation for the desensitization 
phenomenon. 
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